Abstract
To 6 pregnant patients with preterm premature rupture of the membranes, cefuroxime prophylaxis was given 1,500 mg three times daily intravenously. Cefuroxime concentrations were assayed in maternal plasma and amniotic fluid during pregnancy and in umbilical cord blood, placenta, and membranes after delivery. Our results showed a high rate of transplacental transfer of cefuroxime. Bactericidal levels could be demonstrated in maternal plasma, and in amniotic fluid leaking from the vagina. Therapeutically active levels were present in the newborns. The absorption of cefuroxime by the foetal membranes was high. Although the neonatal morbidity in this high-risk population was low, the data are still too preliminary to advise the routine prophylactic use of cefuroxime to pregnant patients with preterm premature rupture of the membranes.
Similar content being viewed by others
References
Gibbs RS, Blanco JD. Premature rupture of the membranes. Obstet Gynecol 1982;60:671–9.
Monif GRG, Hume R, Goodlin RC. Neonatal considerations in the management of premature rupture of the fetal membranes. Obstet Gynecol Rev 1986;41:531–7.
Ohlsson A. Treatments of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989;160:890–906.
Garite TJ, Freeman RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol 1982;59:539–45.
Fayez JA, Hasan AA, Jonas HS, Miller GL. Management of premature rupture of the membranes. Obstet Gynecol 1978;52:17–21.
Toth M, Witkin SS, Ledger W, Thaler H. The role of infection in the etiology of preterm birth. Obstet Gynecol 1988;71:723–6.
Schoonmaker JN, Lawellin DW, Lunt B, McGregor JA. Bacteria and inflammatory cells reduce chorioamniotic membrane integrity and tensile strength. Obstet Gynecol 1989;74:590–6.
Schutte MF, Treffers PE, Soepatmi S. Voortijdig gebroken vliezen [Premature rupture of the membranes]. Ned Tijdschr Geneeskd 1981;125:81–5.
Lebherz TB, Hellman LP, Madding R, Anctil A, Arje SL. Double-blind study of premature rupture of the membranes. Am J Obstet Gynecol 1963;87:218–25.
Miller JM, Brazy JE, Gall SA, Crenshaw MC, Jelovsek FR. Premature rupture of the membranes. Maternal and neonatal infectious morbidity related to betamethasone and antibiotic therapy. J Reprod Med 1980;25:173–7.
Amon E, Lewis SV, Sibai BM, Villar MA, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988;159:539–43.
Craft I, Mullinger BM, Kennedy MRK. Placental transfer of cefuroxime. Br J Obstet Gynaecol 1981;88:141–5.
Bousfield P, Browning AK, Mullinger BM, Elstein M. Cefuroxime: potential use in pregnant women at term. Br J Obstet Gynaecol 1981;88:146–9.
Bergogne-Berezin E, Pierre J, Rouvillois JL, Dumez Y. Placental transfer of cefuroxime in late pregnancy. Drugs Exp Clin Res 1981;7:465–9.
Coppi G, Berti MA, Chehade A, Franchi I, Magro B. A study of the transplacental transfer of cefuroxime in humans. Curr Ther Res 1982;32:712–6.
Philipson A, Stiernstedt G. Pharmacokinetics of cefuroxime in pregnancy. Am J Obstet Gynecol 1982;142:823–8.
Lecaillon JB, Rouan MC, Souppart C, Febvre N, Juge F. Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography. J Chromatogr 1982;228:257–67.
Minkhoff HL, Schwarz RH. The rising cesarean section rate: can it safely be reversed? Obstet Gynecol 1980;56:135–43.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roumen, F.J.M.E., Bouckaert, P.X.J.M., Cremers, H.M.H.G. et al. Pharmacokinetics of cefuroxime in pregnant patients with preterm premature rupture of the membranes. Pharmaceutisch Weekblad Scientific Edition 12, 275–279 (1990). https://doi.org/10.1007/BF01967832
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01967832